ESSA Pharma Inc. — Director's Dealing 2023

Jun 6, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ESSA Pharma Inc. (EPIX)
CIK: 0001633932
Period of Report: 2023-06-06

Reporting Person: Merendino Lauren (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$3.05	2033-06-05	Common Shares (50000)		Direct

Footnotes

F1: Options vest in 36 equal monthly instalments, with the first instalment vesting on the one month anniversary of the grant date, and subsequent instalments vesting on each one month anniversary thereafter.